Ekso Bionics Holdings, Inc.
Hedge Funds Holdings
Last updated:
Ekso Bionics Holdings, Inc.‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 5.06% of the total amount of its stocks outstanding. This makes up a total of 656.06K shares of Ekso Bionics Holdings, Inc.. Compared to the previous quarter, the number fell by -54.24% or -777.66K shares fewer. As for the holding position changes, 5.26% (1) of current hedge fund investors increased the number of shares held, 26.32% (5) of current holders sold a part of the shares held, and 15.79% (3) closed the holdings completely. 4 hedge funds are new holders of Ekso Bionics Holdings, Inc. stock in Q1 2023, it is 21.05% of total holders.
Hedge funds holding Ekso Bionics Holdings (Q2 2018 – Q1 2023)
| Q2 2018 | 36 |
|---|---|
| Q3 2018 | 41 |
| Q4 2018 | 41 |
| Q1 2019 | 51 |
| Q2 2019 | 39 |
| Q3 2019 | 34 |
| Q4 2019 | 35 |
| Q1 2020 | 16 |
| Q2 2020 | 24 |
| Q3 2020 | 19 |
| Q4 2020 | 15 |
| Q1 2021 | 29 |
| Q2 2021 | 28 |
| Q3 2021 | 25 |
| Q4 2021 | 26 |
| Q1 2022 | 23 |
| Q2 2022 | 25 |
| Q3 2022 | 22 |
| Q4 2022 | 28 |
| Q1 2023 | 19 |
Hedge funds changes in Ekso Bionics Holdings positions (Q2 2018 – Q1 2023)
| Q2 2018 | 3 | 7 | 6 | 4 | 16 |
|---|---|---|---|---|---|
| Q3 2018 | 12 | 12 | 5 | 7 | 5 |
| Q4 2018 | 6 | 7 | 8 | 6 | 14 |
| Q1 2019 | 17 | 9 | 7 | 6 | 12 |
| Q2 2019 | 5 | 9 | 6 | 17 | 2 |
| Q3 2019 | 5 | 6 | 8 | 10 | 5 |
| Q4 2019 | 10 | 7 | 5 | 9 | 4 |
| Q1 2020 | 14 | 1 | 1 | 30 | -30 |
| Q2 2020 | 13 | 7 | 2 | 6 | -4 |
| Q3 2020 | 4 | 7 | 3 | 10 | -5 |
| Q4 2020 | 3 | 3 | 6 | 6 | -3 |
| Q1 2021 | 17 | 7 | 4 | 3 | -2 |
| Q2 2021 | 4 | 8 | 7 | 5 | 4 |
| Q3 2021 | 1 | 6 | 7 | 4 | 7 |
| Q4 2021 | 5 | 6 | 5 | 4 | 6 |
| Q1 2022 | 3 | 5 | 6 | 6 | 3 |
| Q2 2022 | 8 | 5 | 4 | 5 | 3 |
| Q3 2022 | 1 | 7 | 7 | 4 | 3 |
| Q4 2022 | 11 | 6 | 5 | 4 | 2 |
| Q1 2023 | 4 | 1 | 5 | 3 | 6 |
Hedge funds changes in Ekso Bionics Holdings stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 132,000 | 0 |
| Q1 2021 | 1,031,000 | 170,000 |
| Q2 2021 | 526,000 | 445,000 |
| Q3 2021 | 559,000 | 188,000 |
| Q4 2021 | 94,000 | 59,000 |
| Q1 2022 | 115,000 | 56,000 |
| Q2 2022 | 63,000 | 75,000 |
| Q3 2022 | 22,000 | 62,000 |
| Q4 2022 | 833 | 9,163 |
| Q1 2023 | 0 | 0 |